ABSTRACT-Background.
Hypercalcemia is a common complication of lung cancer patients, especially in advanced disease. Parathyroid hormone-related protein (PTHrP) is one of the tumor products that play an important role for the formation of this pathological condition. We report herein a case of PTHrP-producing lung cancer associated with secondary diabetes insipidus (DI) due to hypercalcemia. Case. A 67-year-old man was admitted in May, 1999 because of cough and abnormal shadow on chest X-ray. Advanced lung cancer in the left lower lobe was diagnosed and he underwent 3 courses of chemotherapy consisting of cisplatin and docetaxel. A total of 52 Gy radiation therapy was administered to the left hilum to improve the obstruction of the left main bronchus invaded by the tumor 8 months later.
He was readmitted in November, 2000 because of progression of the disease. Chest CT scan showed regrowth of the tumor and complete atelectasis of the left lung. Polydipsia and 3,000-5,000 ml/day polyuria were present during hospitalization. There was no evidence of bone or brain metastasis. Hypercalcemia and high serum levels of C-terminal PTHrP were observed, which strongly suggested secondary DI due to humoral hypercalcemia of malignancy (HHM). Pamidronate disodium was administered of a dose of 30mg, and the hypercalcemia improved immediately. He died due to respiratory failure caused by multiple lung metastasis a month later. We examined the expression of the PTHrP antigen immunohistochemically in the section from the autopsy specimen. Immunoreactivity was measured in the cytoplasm of the tumor cells. Conclusion. We encountered a case of PTHrP-producing lung cancer associated with secondary DI.
Treatment with pamidronate disodium alone was effective for HHM in this patient with cardiopulmonary hypofunction. 
